| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 09/08/2011 | US20110217342 Flashmelt oral dosage formulation |
| 09/08/2011 | US20110217336 Chronotherapeutic dosage forms and methods of treatment using chronotherapy |
| 09/08/2011 | US20110217320 Hapten-carrier conjugates for treating and preventing nicotine addiction |
| 09/08/2011 | US20110217283 Stable galenic freeze-dried pharmaceutical preparation of recombinant carbohydrate-binding polypeptides |
| 09/08/2011 | US20110217255 Block copolymers and their use |
| 09/08/2011 | US20110217245 Substituted Butanol Derivatives And Their Use As Fragrance And Flavor Materials |
| 09/08/2011 | US20110217236 Radiation sensitive liposomes |
| 09/08/2011 | US20110216622 Liposomal apparatus and manufacturing method |
| 09/08/2011 | DE102010002609A1 Partialester eines Polyglycerins mit mindestens einer Carbonsäure und einer polyfunktionalen Carbonsäure, ihre Herstellung und Verwendung Partial esters of polyglycerol with at least one carboxylic acid and a polyfunctional carboxylic acid, their preparation and use |
| 09/07/2011 | EP2363486A1 Monoclonal antibodies and single chain antibody fragments against cell-surface prostate specific membrane antigen |
| 09/07/2011 | EP2363479A1 Oligoribonucucleotide for inhibiting the expression of a predefined gene |
| 09/07/2011 | EP2363478A1 Methods and compositions for inhibiting the function of polynucleotide sequences |
| 09/07/2011 | EP2363424A1 Block copolymers for multifunctional self-assembled systems |
| 09/07/2011 | EP2363404A2 PSMA antibodies |
| 09/07/2011 | EP2363151A1 Poly(amidoamine) oligomer hydrogel for drug delivery and drug carrier using the same |
| 09/07/2011 | EP2363150A1 Compositions and methods for enhancing corticosteroid delivery |
| 09/07/2011 | EP2363145A1 Pharmaceutical anti-TNF-alpha antibody formulation |
| 09/07/2011 | EP2363144A1 Pharmaceutical anti-TNF-alpha antibody formulation |
| 09/07/2011 | EP2363121A1 Pharmaceutical formulation for administration by inhalation comprising an androstane derivative and a beta-2-adrenoreceptor agonist for the treatment of inflammatory and allergic conditions |
| 09/07/2011 | EP2363118A1 Gum resin as a carrier for topical application of pharmacologically active agents |
| 09/07/2011 | EP2363115A2 Complexation of metal ions with polypeptides |
| 09/07/2011 | EP2362784A2 Neurotensin-derived branched peptides and uses thereof |
| 09/07/2011 | EP2362774A1 Anthelmintic compositions |
| 09/07/2011 | EP2362766A2 Pharmaceutical aerosol composition |
| 09/07/2011 | EP2249869B1 Liquid formulation of fsh |
| 09/07/2011 | EP2142171B1 Antifungal foam containing ciclopiroxolamine and zinc pyrithione, and medical and cosmetic applications thereof |
| 09/07/2011 | EP1996625B1 Anti-tat226 antibodies and immunoconjugates |
| 09/07/2011 | EP1924252B1 Method for improving cell permeability to foreign particles |
| 09/07/2011 | EP1758555B2 Triterpene-containing oleogel-forming agent, triterpene-containing oleogel and method for producing a triterpene-containing oleogel |
| 09/07/2011 | CN1886158B Pharmaceutical preparation comprising an antibody against the EGF receptor |
| 09/07/2011 | CN1816562B Protein achieving improved blocking efficiency |
| 09/07/2011 | CN1561230B Antigenic compositions |
| 09/07/2011 | CN102176923A Method of preparing polyglutamate conjugates |
| 09/07/2011 | CN102176913A Tacrolimus preparation for external applications |
| 09/07/2011 | CN102176900A Pharmaceutical compositions and related methods of delivery |
| 09/07/2011 | CN102176898A Stabilized pharmaceutical sub-micron suspensions and methods of forming same |
| 09/07/2011 | CN102174478A Photosensitizer binding protein/polypeptide and application thereof to photodynamic gene therapy |
| 09/07/2011 | CN102174187A Synthetic method of targeted pegylated lipid medicinal material |
| 09/07/2011 | CN102174184A Biodegradable polymer, preparation method thereof and nucleic acid drug delivery carrier |
| 09/07/2011 | CN102174170A Polyurethane material and application thereof as X-ray developing material and magnetic material |
| 09/07/2011 | CN102174140A Novel concentrated positive latex, method for the preparation thereof, and use thereof in industry |
| 09/07/2011 | CN102174123A Production method of water soluble flavone-chitosan derivative |
| 09/07/2011 | CN102174110A Rabies virus glycoprotein-derived peptide and application thereof |
| 09/07/2011 | CN102174106A Anti-Met humanized Fab, anti-Met humanized Fab and doxorubicin conjugate and preparation method and application of anti-Met humanized Fab and doxorubicin conjugate |
| 09/07/2011 | CN102174080A Polypeptide with brain targeted medicine delivery characteristic and preparation method thereof |
| 09/07/2011 | CN102174078A Application of tumor cell membrane selectively penetrating peptide |
| 09/07/2011 | CN102172410A Construction method of targeted nano particle transmission system for cancer diagnosis and treatment |
| 09/07/2011 | CN102172406A Intact minicells as vectors for DNA transfer and gene therapy in vitro and in vivo |
| 09/07/2011 | CN102172405A Multi-arm polymer prodrugs |
| 09/07/2011 | CN102172404A Alkylating recombinant human serum albumin and preparation and application of medicinal composition thereof |
| 09/07/2011 | CN102172397A In vivo targeting of dendritic cells |
| 09/07/2011 | CN102172351A Transdermal therapeutic system for parkinson's disease inducing high plasma levels of rotigotine |
| 09/07/2011 | CN102172347A Oral pharmaceutical formulations comprising fenofibric acid and/or its salts |
| 09/07/2011 | CN102172345A Process for formulating fast dispersing dosage forms comprising at least one fish gelatin selected on the basis of molecular weight |
| 09/07/2011 | CN102172262A Enzyme treatment for infection |
| 09/07/2011 | CN101843607B Composition containing ibutilide fumarate and preparation method and application thereof |
| 09/07/2011 | CN101836997B Glycerol/fructose composite and preparation method thereof |
| 09/07/2011 | CN101816693B Echinacea purpurea extract powder and preparation method and application thereof |
| 09/07/2011 | CN101810577B Gossypol intravenous injection fatty emulsion for curing tumors |
| 09/07/2011 | CN101766650B Washing liquor for operation and method for preparing same |
| 09/07/2011 | CN101724163B Composite microsphere of chitosan derivative, preparing method and applications thereof |
| 09/07/2011 | CN101721717B Method for preparing Fe2O3 nano particle with core-shell structure |
| 09/07/2011 | CN101698104B Method for nucleus-shell turning of waist crosslinked amphiphilic nano micelle |
| 09/07/2011 | CN101693014B Process for preparing coenzyme A medicament freeze drying preparation |
| 09/07/2011 | CN101670111B Preparation method of thioctic acid-glucan conjugate |
| 09/07/2011 | CN101664557B Nano-hydrogel drug carrier material with photosensitivity and temperature sensibility |
| 09/07/2011 | CN101642544B Plaster for treating chronic pelvic inflammation |
| 09/07/2011 | CN101623298B Preparation method of sodium ascorbyl phosphate oral solution |
| 09/07/2011 | CN101618183B Traditional Chinese medicine composition for preventing and treating fatty liver and preparation method thereof |
| 09/07/2011 | CN101600431B Pharmaceutical composition having improved storage stability |
| 09/07/2011 | CN101597337B Conjugate of hydroxyalkyl starch and an active agent |
| 09/07/2011 | CN101590042B Stable oral medicinal composition |
| 09/07/2011 | CN101573118B Aqueous liquid preparation comprising gatifloxacin |
| 09/07/2011 | CN101503480B Microwave synthesizing method for disproportionated rosin-chitosan conjugate |
| 09/07/2011 | CN101474408B Polyethylene glycol monomethyl ether-polycaprolactone-polyphosphate triblock copolymer and siRNA medicament carrier prepared thereby |
| 09/07/2011 | CN101361709B 0Long-acting enrofloxacin injection and preparation method thereof |
| 09/07/2011 | CN101274118B Physiotherapy electrode plate clamping self-pasting medicine carrying membrane and manufacture method thereof |
| 09/07/2011 | CN101259125B Anethol trithione injection emulsion and preparation thereof |
| 09/07/2011 | CN101234139B Proprietary Chinese medicine for curing common cold and preparation thereof |
| 09/07/2011 | CN101209350B Polyglutamate-medicament coupling compound with amino acid as communicating terminal |
| 09/07/2011 | CN101172096B Target controlling and releasing system for magnetic microsphere carrier in bipolar precipitous magnetic field impulse hunting magnetic field |
| 09/07/2011 | CN101163716B Interleukin-6 polyethylene glycol conjugate and its preparing method and use |
| 09/07/2011 | CN101161247B Potassium muriate stomach-inner retention floationg type slow release tablet prepared with shuck powder as carrier |
| 09/07/2011 | CN101134018B Fenofibrate pellet and method for preparing the same |
| 09/07/2011 | CN101120912B Ftibamzone chrisma with PEG-400 as co-solvent |
| 09/07/2011 | CN101068534B Pharmaceutical compositions comprising levetiracetam and process for their preparation |
| 09/06/2011 | US8014854 Method and device for treating abnormal tissue growth with electrical therapy |
| 09/06/2011 | US8013126 84P2A9: a prostate and testis specific protein highly expressed in prostate cancer |
| 09/06/2011 | US8013017 Dermatological compositions and methods |
| 09/06/2011 | US8013013 Formulation and delivery method to enhance antioxidant potency of vitamin E |
| 09/06/2011 | US8012728 Thrombin preparations and process for their production |
| 09/06/2011 | US8012504 Sustained release portion of unit dose containing guaifenesin, dextromethorphan and a release-delaying matrix contains a hydrophilic polymer and a water insoluble polymer, immediate release portion containing guaifenesin |
| 09/06/2011 | US8012498 Topical gel formulation comprising organophosphate insecticide and preparation thereof |
| 09/06/2011 | US8012496 Gastric retention controlled drug delivery system |
| 09/06/2011 | US8012494 at least one non-ionic or zwitterionic surfactant and dispersant; improves the efficacy and/or potency of the lipase inhibitor; inter-subject variability in efficacy and/or potency is reduced, as well as the frequency and intensity of side effects |
| 09/06/2011 | US8012486 Composition for treating atopic dermatitis comprising hirsutenone as an active ingredient |
| 09/06/2011 | US8012485 Drug conjugate composition |
| 09/06/2011 | US8012483 Phosphorylcholine conjugates and corresponding antibodies |
| 09/06/2011 | US8012479 Recombinant toxin fragments |
| 09/06/2011 | US8012476 Molecules with extended half-lives, compositions and uses thereof |